Woong Ju

4.1k total citations · 1 hit paper
99 papers, 3.0k citations indexed

About

Woong Ju is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Woong Ju has authored 99 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 29 papers in Epidemiology and 28 papers in Oncology. Recurrent topics in Woong Ju's work include Cervical Cancer and HPV Research (24 papers), Ovarian cancer diagnosis and treatment (17 papers) and Endometrial and Cervical Cancer Treatments (17 papers). Woong Ju is often cited by papers focused on Cervical Cancer and HPV Research (24 papers), Ovarian cancer diagnosis and treatment (17 papers) and Endometrial and Cervical Cancer Treatments (17 papers). Woong Ju collaborates with scholars based in South Korea, United States and Ethiopia. Woong Ju's co-authors include Seung‐Kwon Myung, Hyuck Jae Choi, Seung Cheol Kim, Yeol Kim, Edward L. Giovannucci, Dagfinn Aune, Darren C. Greenwood, Seung‐Won Oh, Dong Hoon Lee and Byung‐Joo Park and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Woong Ju

95 papers receiving 2.9k citations

Hit Papers

Efficacy of vitamin and antioxidant supplements in preven... 2013 2026 2017 2021 2013 100 200 300

Peers

Woong Ju
Brian W. Walsh United States
Mison Chun South Korea
Denise Scholtens United States
Hong Sun China
Ji‐Yeob Choi South Korea
Janardan D. Khandekar United States
Brian W. Walsh United States
Woong Ju
Citations per year, relative to Woong Ju Woong Ju (= 1×) peers Brian W. Walsh

Countries citing papers authored by Woong Ju

Since Specialization
Citations

This map shows the geographic impact of Woong Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Woong Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Woong Ju more than expected).

Fields of papers citing papers by Woong Ju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Woong Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Woong Ju. The network helps show where Woong Ju may publish in the future.

Co-authorship network of co-authors of Woong Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Woong Ju. A scholar is included among the top collaborators of Woong Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Woong Ju. Woong Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sung, Hye Youn, Ji‐Hye Han, Woong Ju, et al.. (2025). MBNL2 enhances cisplatin resistance by regulating apoptosis in ovarian cancer cells. BMB Reports. 58(5). 224–231.
2.
Ouh, Yung‐Taek, Tae Jin Kim, Woong Ju, et al.. (2024). Development and validation of artificial intelligence-based analysis software to support screening system of cervical intraepithelial neoplasia. Scientific Reports. 14(1). 1957–1957. 14 indexed citations
3.
Sung, Hye Youn, Yun Ju Chae, Woong Ju, et al.. (2023). Identification of a novel PARP4 gene promoter CpG locus associated with cisplatin chemoresistance. BMB Reports. 56(6). 347–352. 8 indexed citations
5.
Kim, Hyun-Jung, Mi‐Kyung Kim, Hye Youn Sung, et al.. (2019). SPSB1 enhances ovarian cancer cell survival by destabilizing p21. Biochemical and Biophysical Research Communications. 510(3). 364–369. 10 indexed citations
6.
Jin, Yingji, Jae Woong Choi, Hyoung Jin Kim, et al.. (2018). Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer. Cancer Medicine. 7(11). 5655–5664. 5 indexed citations
7.
Kim, Hyun-Jung, Sun Hee Sung, Chan Young Kim, et al.. (2017). 14-3-3ζ Overexpression is Associated with Poor Prognosis in Ovarian Cancer. Yonsei Medical Journal. 59(1). 51–51. 10 indexed citations
8.
Kim, Chan Young, et al.. (2017). Aberrant single‐minded homolog 1 methylation as a potential biomarker for cervical cancer. Diagnostic Cytopathology. 46(1). 15–21. 16 indexed citations
9.
Jin, Yingji, et al.. (2016). Increased sialylation and reduced fucosylation of exfoliated cervical cells are potential markers of carcinogenesis in the cervix. Clinical Chemistry and Laboratory Medicine (CCLM). 54(11). 1811–1819. 11 indexed citations
10.
Kim, Jiyoung, Yi‐Jun Kim, Rena Lee, et al.. (2016). Treatment outcomes after adjuvant radiotherapy following surgery for patients with stage I endometrial cancer. Radiation Oncology Journal. 34(4). 265–272. 7 indexed citations
11.
Jung, Hun, Nirmal Rajasekaran, Woong Ju, & Young Kee Shin. (2015). Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer. Journal of Clinical Medicine. 4(5). 1126–1155. 35 indexed citations
12.
Myung, Seung‐Kwon, Woong Ju, B. Cho, et al.. (2013). Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 346(jan18 1). f10–f10. 346 indexed citations breakdown →
14.
Ju, Woong, Byong Chul Yoo, Il-Jin Kim, et al.. (2009). Identification of Genes With Differential Expression in Chemoresistant Epithelial Ovarian Cancer Using High-Density Oligonucleotide Microarrays. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 18(2). 47–56. 71 indexed citations
15.
Jung, Dae Chul, et al.. (2007). Discordant MRI/FDG-PET imaging for the diagnosis of borderline ovarian tumors. International Journal of Gynecological Cancer. 18(4). 637–641. 12 indexed citations
16.
Ju, Woong, Jae‐Weon Kim, Yong Sang Song, et al.. (2007). Matrix metalloproteinase‐1 promoter polymorphism and epithelial ovarian cancer: Does ethnicity matter?. Journal of obstetrics and gynaecology research. 33(2). 155–160. 27 indexed citations
17.
Kang, Sokbom, Woong Ju, Jae‐Weon Kim, et al.. (2006). Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer. Experimental & Molecular Medicine. 38(3). 320–324. 75 indexed citations
18.
Ju, Woong, Byong Chul Yoo, Il-Jin Kim, Jae‐Weon Kim, & Seung Cheol Kim. (2006). Identification of genes with differential expression in platinum-resistant epithelial ovarian cancer using high-density oligonucleotide microarrays.. Cancer Epidemiology and Prevention Biomarkers. 15(2). 763. 1 indexed citations
19.
Kim, Seungchang, et al.. (2006). CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer. International Journal of Gynecological Cancer. 16(S1). 190–194. 6 indexed citations
20.
Ju, Woong, et al.. (2006). Loss of hMLH1 expression is associated with less aggressive clinicopathological features in sporadic endometrioid endometrial adenocarcinoma. Journal of obstetrics and gynaecology research. 32(5). 454–460. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026